Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 3.20% is 179% above its 5-year average of -4.06%, near the high end of its 5-year range (-17.40%–9.75%).
31.11% below its 12-month average of 4.65%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): 9.75%.
EBITDA MARGIN
3.20%
EBITDA MARGIN AVG TTM
4.65%
EBITDA MARGIN AVG 3Y
-0.34%
EBITDA MARGIN AVG 5Y
-4.06%
EBITDA MARGIN AVG 10Y
-7.47%
EBITDA MARGIN AVG 15Y
-8.51%
EBITDA MARGIN AVG 20Y
-9.55%
CURRENT VS TTM AVG
-31.11%
CURRENT VS 3Y AVG
+1035.51%
CURRENT VS 5Y AVG
+178.84%
CURRENT VS 10Y AVG
+142.82%
CURRENT VS 15Y AVG
+137.58%
CURRENT VS 20Y AVG
+133.49%
Market Cap
$2.80B
EBITDA Margin
22.42%
TTM Avg
17.70%
3Y Avg
-0.76%
5Y Avg
-37.34%
Market Cap
$2.86B
EBITDA Margin
89.92%
TTM Avg
49.57%
3Y Avg
44.47%
5Y Avg
4968.54%
Market Cap
$2.71B
EBITDA Margin
-1067.75%
TTM Avg
-2196.34%
3Y Avg
-1532.38%
5Y Avg
-1148.77%
Market Cap
$2.70B
EBITDA Margin
17.42%
TTM Avg
19.36%
3Y Avg
20.74%
5Y Avg
18.34%
Market Cap
$2.70B
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.68B
EBITDA Margin
11.88%
TTM Avg
11.88%
3Y Avg
7.44%
5Y Avg
-2.29%
Market Cap
$2.68B
EBITDA Margin
11.52%
TTM Avg
13.31%
3Y Avg
15.86%
5Y Avg
16.56%
Market Cap
$2.60B
EBITDA Margin
-270.04%
TTM Avg
-444.88%
3Y Avg
-365.27%
5Y Avg
-89273.54%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AtriCure, Inc. (ATRC) | $2.80B | 3.20% | 4.65% | -0.34% | -4.06% |
| TransMedics Group, Inc. (TMDX)vs › | $2.80B | 22.42% | 17.70% | -0.76% | -37.34% |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.86B | 89.92% | 49.57% | 44.47% | 4968.54% |
| Precigen, Inc. (PGEN)vs › | $2.71B | -1067.75% | -2196.34% | -1532.38% | -1148.77% |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.70B | 17.42% | 19.36% | 20.74% | 18.34% |
| MBX Biosciences, Inc. Common Stock (MBX)vs › | $2.70B | N/A | N/A | N/A | N/A |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.68B | 11.88% | 11.88% | 7.44% | -2.29% |
| Neogen Corporation (NEOG)vs › | $2.68B | 11.52% | 13.31% | 15.86% | 16.56% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.60B | -270.04% | -444.88% | -365.27% | -89273.54% |
| NewAmsterdam Pharma Company N.V. (NAMS)vs › | $2.59B | -1001.92% | -694.29% | -672.56% | -672.56% |
Gross Margin
76.2%
EBITDA Margin
3.2%
Operating Margin
2.4%
Net Margin
1.9%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 9.75% |
| 2026-03-31 | 4.11% |
| 2025-12-31 | 6.12% |
| 2025-09-30 | 4.00% |
| 2025-06-30 | -0.75% |
| 2025-03-31 | -0.70% |
| 2024-12-31 | -7.80% |
| 2024-09-30 | -2.14% |
| 2024-06-30 | -2.27% |
| 2024-03-31 | -5.94% |
| 2023-12-31 | -4.21% |
| 2023-09-30 | -4.05% |
| 2023-06-30 | -0.56% |
| 2023-03-31 | -3.04% |
| 2022-12-31 | -1.38% |
| 2022-09-30 | -9.29% |
| 2022-06-30 | -12.69% |
| 2022-03-31 | -15.13% |
| 2021-12-31 | -13.21% |
| 2021-09-30 | -8.66% |
| 2021-06-30 | -17.40% |
| 2021-03-31 | -23.22% |
| 2020-12-31 | -26.57% |
| 2020-09-30 | -2.76% |
| 2020-06-30 | -11.82% |
| 2020-03-31 | -24.44% |
| 2019-12-31 | -21.11% |
| 2019-09-30 | -11.03% |
| 2019-06-30 | -2.51% |
| 2019-03-31 | -5.73% |
| 2018-12-31 | -0.73% |
| 2018-09-30 | -7.85% |
| 2018-06-30 | 6.10% |
| 2018-03-31 | -15.39% |
| 2017-12-31 | 0.30% |
| 2017-09-30 | -10.87% |
| 2017-06-30 | -9.00% |
| 2017-03-31 | -17.78% |
| 2016-12-31 | -12.77% |
| 2016-09-30 | -10.25% |
| 2016-06-30 | -13.74% |
| 2016-03-31 | -20.06% |
| 2015-12-31 | -23.88% |
| 2015-09-30 | -14.66% |
| 2015-06-30 | -10.55% |
| 2015-03-31 | -12.83% |
| 2014-12-31 | -11.82% |
| 2014-09-30 | 1.69% |
| 2014-06-30 | -6.49% |
| 2014-03-31 | -27.53% |
| 2013-12-31 | -19.57% |
| 2013-09-30 | -10.45% |
| 2013-06-30 | -5.59% |
| 2013-03-31 | -6.89% |
| 2012-12-31 | -8.02% |
| 2012-09-30 | -12.78% |
| 2012-06-30 | -4.08% |
| 2012-03-31 | -5.52% |
| 2011-12-31 | -7.55% |
| 2011-09-30 | -5.10% |
| 2011-06-30 | -1.33% |
| 2011-03-31 | -3.48% |
| 2010-12-31 | 2.13% |
| 2010-09-30 | -2.02% |
| 2010-06-30 | 1.22% |
| 2010-03-31 | -7.59% |
| 2009-12-31 | -10.78% |
| 2009-09-30 | -28.83% |
| 2009-06-30 | -3.12% |
| 2009-03-31 | -53.76% |
| 2008-12-31 | -24.38% |
| 2008-09-30 | -7.27% |
| 2008-06-30 | -7.67% |
| 2008-03-31 | -23.34% |
| 2007-12-31 | -7.36% |
| 2007-09-30 | -19.02% |
| 2007-06-30 | -21.18% |
| 2007-03-31 | -40.64% |
| 2006-12-31 | -37.12% |
| 2006-09-30 | -31.11% |
| 2006-06-30 | -32.08% |
| 2006-03-31 | -34.07% |
| 2005-12-31 | -44.43% |
| 2005-09-30 | -46.58% |
| 2005-06-30 | -13.29% |
| 2005-03-31 | -14.83% |
| 2004-12-31 | -39.35% |
| 2004-09-30 | -32.29% |
